Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

byMichael Horton

August 15, 2022

1 minute read

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

RBC Capital Maintains Sector Perform on Lincoln National, Lowers Price Target to $57

By Benzinga Newsdesk

August 5, 7:34 AM

RBC Capital analyst Mark Dwelle maintains Lincoln National (NYSE:LNC) with a Sector Perform and lowers the price target from $71 to $57.

LNC

Why Computer Networking Company Arista’s Shares Are Surging Today

By Lekha Gupta

October 31, 8:18 AM

Arista Networks Inc (NYSE: ANET) shares are trading higher by around 10% after the company

ANET

Earnings

Earnings Scheduled For June 20, 2023

By Benzinga Insights

June 20, 5:54 AM

Companies Reporting Before The Bell • Smart Share Glb (NASDAQ:EM) is likely to report quarterly loss at $0.02 per share on revenue of $114.09 million.

DLNG

News

Biophytis Receives Notice Of Delisting From Nasdaq And Announces It Will Request A Hearing Before The Nasdaq Hearings Panel

By Benzinga Newsdesk

October 27, 5:30 PM

October 27, 2023 / Biophytis SA ((NASDAQ CM:BPTS, PARIS:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes

BPTS

Revelation Biosciences Q2 EPS $(0.12)

Related Posts

RBC Capital Maintains Sector Perform on Lincoln National, Lowers Price Target to $57

Why Computer Networking Company Arista’s Shares Are Surging Today

Earnings Scheduled For June 20, 2023

Biophytis Receives Notice Of Delisting From Nasdaq And Announces It Will Request A Hearing Before The Nasdaq Hearings Panel